Open AccessNonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
Author(s) -
Salvatore Magrì,
Danilo Paduano,
Fabio Chicco,
Arianna Cingolani,
Cristiana Farris,
Giovanna Delogu,
Francesca Tumbarello,
Michela Lai,
Alessandro Melis,
Laura Casula,
Massimo Fantini,
Paolo Usai
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i37.5676
Subject(s) - nonalcoholic fatty liver disease , medicine , gastroenterology , metabolic syndrome , transient elastography , inflammatory bowel disease , fatty liver , body mass index , odds ratio , ulcerative colitis , steatosis , liver biopsy , obesity , disease , biopsy
Nonalcoholic fatty liver disease (NAFLD) is a frequently reported condition in patients with inflammatory bowel disease (IBD). Both intestinal inflammation and metabolic factors are believed to contribute to the pathogenesis of IBD-associated NAFLD.